In both low and high doses, the signal enhancements in 3xTg AD and APP/PS/Tau mouse models were mainly concentrated on hippocampus C1&C2&C3&DG, hippocampus C3, cortex, and thalamus. This evidence concerns the gene APP and Alzheimer disease.